EMAIL THIS PAGE TO A FRIEND

American journal of hematology

Enrichment of reticulocytes from whole blood using aqueous multiphase systems of polymers.


PMID 25263455

Abstract

This paper demonstrates the enrichment of reticulocytes by centrifuging whole blood through aqueous multiphase systems (AMPSs)-immiscible phases of solutions of polymers that form step-gradients in density. The interfaces of an AMPS concentrate cells; this concentration facilitates the extraction of blood enriched for reticulocytes. AMPS enrich reticulocytes from blood from both healthy and hemochromatosis donors. Varying the osmolality and density of the phases of AMPS provides different levels of enrichment and yield of reticulocytes. A maximum enrichment of reticulocytemia of 64 ± 3% was obtained from donors with hemochromatosis. When used on peripheral blood from normal donors, AMPS can provide a higher yield of enriched reticulocytes and a higher proportion of reticulocytes expressing CD71 than differential centrifugation followed by centrifugation over Percoll. Blood enriched for reticulocytes by AMPS could be useful for research on malaria. Several species of malaria parasites show a preference to invade young erythrocytes and reticulocytes; this preference complicates in vitro cultivation of these species in human blood. Plasmodium knowlesi malaria parasites invade normal human blood enriched for reticulocytes by AMPSs at a rate 2.2 times greater (P < 0.01) than they invade unenriched blood. Parasite invasion in normal blood enriched by AMPS was 1.8 times greater (P < 0.05) than in blood enriched to a similar reticulocytemia by differential centrifugation followed by centrifugation over Percoll. The enrichment of reticulocytes that are invaded by malaria parasites demonstrates that AMPSs can provide a label-free method to enrich cells for biological research.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D0731000 Dextran, European Pharmacopoeia (EP) Reference Standard
D0731005 Dextran 1, European Pharmacopoeia (EP) Reference Standard
D0734000 Dextran 10 for calibration, European Pharmacopoeia (EP) Reference Standard
D0737000 Dextran 250 for calibration, European Pharmacopoeia (EP) Reference Standard
D0733000 Dextran 4 for calibration, European Pharmacopoeia (EP) Reference Standard
D0735000 Dextran 40 for calibration, European Pharmacopoeia (EP) Reference Standard
D0738000 Dextran 40 for performance test, European Pharmacopoeia (EP) Reference Standard
D0739000 Dextran 60/70 for performance test, European Pharmacopoeia (EP) Reference Standard
D0736000 Dextran 70 for calibration, European Pharmacopoeia (EP) Reference Standard
D0732000 Dextran Vo, European Pharmacopoeia (EP) Reference Standard
Y0000441
Didanosine impurity A,, European Pharmacopoeia (EP) Reference Standard
C5H4N4O
77662
Hypoxanthine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.
C5H4N4O
H9377
Hypoxanthine, ≥99.0%
C5H4N4O
H9636
Hypoxanthine, powder, BioReagent, suitable for cell culture
C5H4N4O
M9140
Methylene blue, certified by the Biological Stain Commission
C16H18ClN3S · xH2O
03978
Methylene Blue solution, for microscopy, concentrate according to Ehrlich, concentrated, aqueous solution
C16H18ClN3S
1808
Methylene Blue solution, 1.4 % (w/v) in 95% ethanol
C16H18ClN3S
319112
Methylene Blue solution, 0.05 wt. % in H2O
C16H18ClN3S
77515
Methylene Blue solution, for microscopy
C16H18ClN3S
50484
Methylene Blue solution, for microbiology
C16H18ClN3S
66725
Methylene Blue solution alkaline according to Loeffler, according to Loeffler
C16H18ClN3S
Y0001550
Poly(vinyl alcohol), European Pharmacopoeia (EP) Reference Standard